Comparison of platelet reactivity and clopidogrel response in patients ≤75 years versus >75 years undergoing percutaneous coronary intervention for nonST-segment elevation acute coronary syndrome

American Journal of Cardiology

Volumn 108, Issue 10, 2011, Pages 1411-1416

  Cuisset, Thomas ^a,b   Quilici, Jacques ^a   Grosdidier, Charlotte ^b   Fourcade, Laurent ^c   Gaborit, Bénédicte ^b   Pankert, Mathieu ^a   Molines, Laurent ^b   Morange, Pierre Emmanuel ^b   Bonnet, Jean Louis ^a   Alessi, Marie Christine ^b  

^a TIMONE HOSPITAL   (France)

^b INSERM   (France)

^c LAVERAN MILITARY TEACHING HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; AGE SPECIFIC CARE; AGED; ARTICLE; BLEEDING; COMPARATIVE STUDY; CORONARY STENT; DRUG MEGADOSE; FEMALE; GERIATRIC PATIENT; HUMAN; ISCHEMIA; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TREATMENT RESPONSE;

ACUTE CORONARY SYNDROME; ADENOSINE DIPHOSPHATE; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; DRUG RESISTANCE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RECURRENCE; STENTS; TICLOPIDINE;

EID: 80255137260     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.06.060     Document Type: Article

References (26)

1. M.E. Bertrand, H.J. Rupprecht, P. Urban, A.H. Gershlick CLASSICS Investigators Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS) Circulation 102 2000 624 629 (Pubitemid 30640661)
2. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
3. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, M.K. Natarajan, K. Malmberg, H. Rupprecht, F. Zhao, S. Chrolavicius, I. Copland, K.A. Fox Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
4. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, F. Alfonso, C. Macaya, T.A. Bass, and M.A. Costa Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516 (Pubitemid 46517957)
5. S. Matetzky, B. Shenkman, V. Guetta, M. Schechter, R. Bienart, I. Goldenberg, I. Novikov, H. Pres, N. Savion, D. Varon, and H. Hod Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
6. T. Cuisset, C. Frere, J. Quilici, F. Barbou, P.E. Morange, T. Hovasse, J.L. Bonnet, and M.C. Alessi High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome J Thromb Haemost 4 2006 542 549
7. T. Geisler, H. Langer, M. Wydymus, K. Göhring, C. Zrn, B. Bigalke, K. Stellos, A.E. May, and M. Gawaz Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation Eur Heart J 27 2006 2420 2425 (Pubitemid 44522148)
8. W. Hochholzer, D. Trenk, H.P. Bestehorn, B. Fischer, C.M. Valina, M. Ferenc, M. Gick, A. Caputo, H.J. Bttner, and F.J. Neumann Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement J Am Coll Cardiol 48 2006 1742 1750 (Pubitemid 44648629)
9. P. Buonamici, R. Marcucci, A. Migliorini, G.F. Gensini, A. Santini, R. Paniccia, G. Moschi, A.M. Gori, R. Abbate, and D. Antoniucci Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis J Am Coll Cardiol 49 2007 2312 2317 (Pubitemid 46891710)
10. T. Cuisset, G. Cayla, C. Frere, J. Quilici, R. Poyet, B. Gaborit, L. Bali, P.E. Morange, M.C. Alessi, and J.L. Bonnet Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome: shifting from antiplatelet resistance to bleeding risk assessment? EuroIntervention 5 2009 325 329
11. D. Sibbing, S. Schulz, S. Braun, T. Morath, J. Stegherr, J. Mehilli, A. Schömig, N. von Beckerath, and A. Kastrati Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement J Thromb Haemost 8 2010 250 256
12. K.P. Alexander, L.K. Newby, C.P. Cannon, P.W. Armstrong, W.B. Gibler, M.W. Rich, F. Van de Werf, H.D. White, W.D. Weaver, M.D. Naylor, J.M. Gore, H.M. Krumholz, E.M. Ohman American Heart Association Council on Clinical Cardiology Society of Geriatric Cardiology Society of Geriatric Cardiology Acute coronary care in the elderly, part I: NonST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2007 2549 2569 (Pubitemid 46766536)
13. K.P. Alexander, L.K. Newby, P.W. Armstrong, C.P. Cannon, W.B. Gibler, M.W. Rich, F. Van de Werf, H.D. White, W.D. Weaver, M.D. Naylor, J.M. Gore, H.M. Krumholz, E.M. Ohman American Heart Association Council on Clinical Cardiology Society of Geriatric Cardiology Society of Geriatric Cardiology Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2007 2570 2589 (Pubitemid 46766537)
14. A. Avezum, M. Makdisse, F. Spencer, J.M. Gore, K.A. Fox, G. Montalescot, K.A. Eagle, K. White, R.H. Mehta, E. Knobel, J.P. Collet GRACE Investigators Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE) Am Heart J 149 2005 67 73 (Pubitemid 40126492)
15. W. Hochholzer, D. Trenk, M.F. Fromm, C.M. Valina, C. Stratz, H.P. Bestehorn, H.J. Bttner, and F.J. Neumann Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement J Am Coll Cardiol 55 2010 2427 2434
16. T. Gremmel, S. Steiner, D. Seidinger, R. Koppensteiner, S. Panzer, and C.W. Kopp Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel J Thromb Haemost 8 2010 37 42
17. S.R. Mehta, J.P. Bassand, S. Chrolavicius, R. Diaz, J.W. Eikelboom, K.A. Fox, C.B. Granger, S. Jolly, C.D. Joyner, H.J. Rupprecht, P. Widimsky, R. Afzal, J. Pogue, S. Yusuf CURRENT-OASIS. 7 Investigators Dose comparisons of clopidogrel and aspirin in acute coronary syndromes N Engl J Med 363 2010 930 942
18. U.R. Schwarz, J. Geiger, U. Walter, and M. Eigenthaler Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human plateletsdefinition and detection of ticlopidine/clopidogrel effects Thromb Haemost 82 1999 1145 1152 (Pubitemid 29419734)
19. L. Bonello, U.S. Tantry, R. Marcucci, R. Blindt, D.J. Angiolillo, R. Becker, D.L. Bhatt, M. Cattaneo, J.P. Collet, T. Cuisset, C. Gachet, G. Montalescot, L.K. Jennings, D. Kereiakes, D. Sibbing, D. Trenk, J.W. Van Werkum, F. Paganelli, M.J. Price, R. Waksman, P.A. Gurbel Working Group on High On-Treatment Platelet Reactivity Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
20. W.K. Laskey, C.W. Yancy, and W.H. Maisel Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 78, 2006 Circulation 115 2007 2352 2357 (Pubitemid 46685904)
21. T. Cuisset, C. Frere, R. Poyet, J. Quilici, B. Gaborit, L. Bali, O. Brissy, M. Lambert, P.E. Morange, M.C. Alessi, and J.L. Bonnet Clopidogrel response: head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting Arch Cardiovasc Dis 103 2010 39 45
22. D.J. Angiolillo, A. Fernández-Ortiz, E. Bernardo, C. Barrera Ramírez, M. Sabaté, C. Fernandez, R. Hernández- Antolín, J. Escaned, F. Alfonso, and C. Macaya Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted? J Invasive Cardiol 16 2004 169 174 (Pubitemid 38456448)
23. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
24. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington PLATO Investigators A. Freij, and M. Thorsén Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
25. M.J. Price, P.B. Berger, P.S. Teirstein, J.F. Tanguay, D.J. Angiolillo, D. Spriggs, S. Puri, M. Robbins, K.N. Garratt, O.F. Bertrand, M.E. Stillablower, J.R. Aragon, D.E. Kandzari, C.T. Stinis, M.S. Lee, S.V. Manoukian, C.P. Cannon, N.J. Schork, E.J. Topol GRAVITAS Investigators Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
26. J.P. Collet, G. Cayla, T. Cuisset, S. Elhadad, G. Rangé, E. Vicaut, and G. Montalescot Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study Am Heart J 161 2011 5 12